将神经营养因子和生物活性与阿尔茨海默氏症疾病联系起来
Minhui Wei1, Tong Wu1, Ning Chen1
1Tianjiu Research and Development Center for Exercise Nutrition and Foods, Hubei Key Laboratory of Exercise Training and Monitoring, College of Sports Medicine, Wuhan Sports University, Wuhan 430079, China.
Ageing research reviews
|December 24, 2023
概括
这就是阿尔茨海默病的原因.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
背景情况:
- 由于人口老龄化,阿尔茨海默氏症 (AD) 是一个日益严重的公共卫生问题.
- 阿尔茨海默病的复杂病原体目前缺乏有效的治疗方法.
- 生物活性的神经保护作用如BDNF,NGF,虹膜素和氨酸在AD中越来越被认可.
研究的目的:
- 为了审查阿尔茨海默病的发病过程.
- 分析内源和外源生物活性对AD病变的调节作用.
- 确定新的治疗点,并支持在AD辅助治疗中使用生物活性.
主要方法:
- 关于阿尔茨海默氏症病原学的文献综述.
- 对神经营养因子和生物活性 (内源和外源) 的研究分析.
- 综合当前关于阿尔茨海默病中基于的神经保护的研究.
主要成果:
- 生物活性,包括神经变因子,表现出与AD相关的神经保护功能.
- 内源性和外源性都显示出调节AD病变发生的潜力.
- 可以为AD的新型治疗策略提供有前途的途径.
结论:
- 生物活性代表了AD治疗发展的重要领域.
- 了解AD病变的调节可以为未来的治疗策略提供信息.
- 可以作为阿尔茨海默病的有价值的辅助疗法.
更多相关视频
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
9.3K
06:23Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
8.0K
相关概念视频
Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Role of Neurotransmitters in Memory
565
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
565
Enzyme-linked Receptors
78.5K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.5K
